ストックスクリーナーアプリを入手
35.10
9.04%
2.91
アフターアワーズ：
35.70
0.60
+1.71%
Rapt Therapeutics Inc (RAPT) 最新ニュース
Breakout Zone: Should I set a stop loss on Volcon IncJuly 2025 Short Interest & High Return Trade Guides - baoquankhu1.vn
Rapt Therapeutics (NASDAQ:RAPT) Trading Down 6.8%What's Next? - MarketBeat
Rapt Therapeutics (NASDAQ:RAPT) Short Interest Update - MarketBeat
RAPT: Ozureprobart advances with strong phase 2 data, targeting broad allergic disorders and unmet needs - TradingView — Track All Markets
RAPT: Ozureprobart advances with less frequent dosing and broader efficacy, targeting major allergic disorders - TradingView — Track All Markets
RAPT Therapeutics, Inc. Announces Participation in JPM Healthcare Conference - TradingView — Track All Markets
Rapt Therapeutics (NASDAQ:RAPT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Rapt Therapeutics (NASDAQ:RAPT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Shares Gap Up – Time to Buy? - Defense World
Rapt Therapeutics (NASDAQ:RAPT) Coverage Initiated at Piper Sandler - Defense World
Published on: 2026-01-11 11:16:12 - Улправда
Piper Sandler Initiates RAPT Therapeutics(RAPT.US) With Buy Rating, Announces Target Price $95 - 富途牛牛
Published on: 2026-01-11 01:06:13 - Улправда
Will RAPT Therapeutics Inc. stock maintain dividend yield2025 Market Trends & Reliable Intraday Trade Alerts - Улправда
How RAPT Therapeutics Inc. stock benefits from global expansionQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - Улправда
Rapt Therapeutics (NASDAQ:RAPT) Upgraded to "Strong-Buy" at Piper Sandler - MarketBeat
Rapt Therapeutics (NASDAQ:RAPT) Shares Gap UpTime to Buy? - MarketBeat
Piper Sandler initiates coverage on Rapt Therapeutics stock with Overweight rating - Investing.com Canada
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
Will RAPT Therapeutics Inc. (0RA0) stock benefit from Fed rate cutsMarket Sentiment Review & Low Volatility Stock Suggestions - Улправда
RAPT Therapeutics, Inc.Common Stock (NQ: RAPT - FinancialContent
RAPT Therapeutics to Present Company Overview at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Rapt Therapeutics (NASDAQ:RAPT) Shares Up 7%Time to Buy? - MarketBeat
User | malvern-online.comRAPT Therapeutics, Inc.Common Stock (Nasdaq:RAPT) Stock Quote - FinancialContent
Rapt Therapeutics (NASDAQ:RAPT) Trading Down 4%Should You Sell? - MarketBeat
Can RAPT Therapeutics Inc. stock sustain institutional interestSupport and Resistance Levels & Budget Friendly Trading Ideas - bollywoodhelpline.com
RAPT Therapeutics (RAPT) Is Up 8.0% After Index Additions And Trial Progress News Has The Bull Case Changed? - simplywall.st
RAPT Therapeutics (RAPT) Joins Key Biotech Index Is Its Investor Story Entering a New Phase? - Yahoo Finance
Rapt Therapeutics (NASDAQ:RAPT) Trading 9.8% HigherWhat's Next? - MarketBeat
RAPT Therapeutics, Inc.(NasdaqGM:RAPT) added to S&P Biotechnology Select Industry Index - marketscreener.com
Can RAPT Therapeutics Inc. (0RA0) stock resist broad market declinesQuarterly Growth Report & Safe Entry Zone Identification - Улправда
TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy” - Insider Monkey
TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a "Buy" - Finviz
Certain Pre Funded warrants of RAPT Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2025. - marketscreener.com
Certain Options of RAPT Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2025. - marketscreener.com
Certain Common Stock of RAPT Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-DEC-2025. - marketscreener.com
Is RAPT Therapeutics Inc. (0RA) stock a top dividend aristocrat candidateRisk Management & Free Daily Entry Point Trade Alerts - Улправда
Will RAPT Therapeutics Inc. stock outperform value stocksJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - Улправда
Rapt Therapeutics (NASDAQ:RAPT) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
12 Best Multibagger Stocks to Buy Heading into 2026 - Insider Monkey
Will RAPT Therapeutics Inc. stock deliver long term returnsJuly 2025 Trends & Free Community Consensus Stock Picks - Улправда
Is RAPT Therapeutics Inc. (0RA) stock among top earnings playsMarket Performance Summary & Stepwise Swing Trade Plans - ulpravda.ru
Rapt Therapeutics (NASDAQ:RAPT) Now Covered by TD Cowen - Defense World
Published on: 2025-12-19 09:56:31 - Улправда
Published on: 2025-12-19 01:07:45 - Улправда
Why analysts maintain buy rating on RAPT Therapeutics Inc. (0RA0) stockInsider Buying & Accurate Buy Signal Alerts - Улправда
TD Cowen Initiates Coverage on RAPT Therapeutics With Buy Rating - marketscreener.com
Rapt Therapeutics (NASDAQ:RAPT) Coverage Initiated at TD Cowen - MarketBeat
TD Cowen initiates coverage on Rapt Therapeutics stock with Buy rating - Investing.com Canada
Rapt Therapeutics (NASDAQ:RAPT) Stock Price Down 9.2%Should You Sell? - MarketBeat
RAPT Therapeutics, Inc. (NASDAQ:RAPT) surges 5.3%; individual investors who own 34% shares profited along with institutions - Yahoo Finance
Rapt Therapeutics (NASDAQ:RAPT) Trading Up 4.9%Here's Why - MarketBeat
BVF Inc. IL Trims Holdings in Rapt Therapeutics $RAPT - MarketBeat
4.73%
0.92%
大文字化:
|
ボリューム (24 時間):